Michael Myers insider trades: Quoin Pharmaceuticals (QNRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | QNRX | ↑ Buy | 20,490 | $4.88 | $100K | Direct | Sep 1, 2026 (1d) |
| Dec 23, 2024 | QNRX | ↑ Buy | 555,556 | $0.45 | $250K | Direct | Dec 27, 2024 (4d) |
| Sep 4, 2024 | QNRX | ↑ Buy | 37,894 | $0.76 | $29K | Direct | Sep 5, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other QNRX insiders
Open-market trades in the last 12 months
About Michael Myers's insider trades
Michael Myers is Chief Executive Officer at Quoin Pharmaceuticals (QNRX). Since Sep 4, 2024, Michael has reported 3 open-market purchases worth $379K and no sales on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include grants and awards (4 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every QNRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.